Certain Ordinary Shares of Zealand Pharma A/S are subject to a Lock-Up Agreement Ending on 2-JAN-2023. These Ordinary Shares will be under lockup for 90 days starting from 4-OCT-2022 to 2-JAN-2023.
Details:
The members of Zealand's executive management and board of directors will be subject to a 90 calendar days lock-up undertaking (calculated from October 4, 2022), both subject to certain customary exceptions and an exemption related to a limited number of shares subscribed for by exercise of warrants which can be subscribed for by certain members of the executive management and board of directors.